Dr. Mrignayani Kotecha, PhD, is a founding member and the CEO of O2M Technologies, LLC since its inception in Feb 2017. The company was formed with the purpose of bringing pulse electron paramagnetic resonance oxygen imaging (EPROI) to the market. Our commitment is to use oxygen imaging to build better cancer and regenerative medicine therapies. Prior to starting O2M, Dr. Kotecha was a research faculty in bioengineering department at University of Illinois at Chicago, a staff scientist at the University of Duisburg-Essen (Germany) and the Weizmann Institute of Science (Israel), and an assistant professor of Physics at the Government Model Science College, Jabalpur, India. Dr. Kotecha is the author of six book chapters, author or co-author of more than 30 peer-reviewed publications and an ASTM standard. Dr. Kotecha is the lead editor of 2017 Wiley book “Magnetic Resonance Imaging in Tissue Engineering” and the task group chair for 2017 ASTM standard F3224-17 “Standard Test Method for Evaluating Growth of Engineered Cartilage Tissue using Magnetic Resonance Imaging”.